Zbigniew Markowski - HELIX BIOPHARMA CEO

HBP Stock  EUR 0.12  0.02  14.29%   

CEO

Dr. Zbigniew Markowski is Chief Executive Officer of the Company. Dr. Markowski comes with a diversified experience having had a career in business university and government. Among others from 2006 until January 10 2016 he served as Chairman of O.M. Finance Ltd a private investment and consulting company from 1998 to 2002 as vicechairman of Prokom Investments SA a Polish investment fund where he was responsible for the financial and pharmaceutical sectors and as Member of the Board of BIOTON SA a pharmaceutical company listed on the Warsaw Stock Exchange from 1993 to 2005 he was a leading coordinator for more than a dozen initial public offerings of Polish companies listed on the WSE. From 1995 he was member or Chairman of the Supervisory Board of many companies listed on the WSE and additionally he served as chairman of the Audit Committees of CIECH SA II NFI SA and ROBYG SA.In 1993 he served as Special Plenipotentiary to the Minister of Privatization and to the Minister of Foreign Trade and in 1994 he was appointed as Commercial Counselor of the Polish People Republic in Stockholm Sweden since 2016.
Tenure 8 years
Professional MarksPh.D
Markowski holds a PhD in Economics from the University of Gdansk.
HELIX BIOPHARMA (HBP) is traded on Berlin Exchange in Germany and employs 14 people.

HELIX BIOPHARMA Leadership Team

Elected by the shareholders, the HELIX BIOPHARMA's board of directors comprises two types of representatives: HELIX BIOPHARMA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HELIX. The board's role is to monitor HELIX BIOPHARMA's management team and ensure that shareholders' interests are well served. HELIX BIOPHARMA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HELIX BIOPHARMA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Albert Beraldo, Director
Artur Gabor, Independent Director
Steve Demas, COO
Marek Orlowski, Independent Director
Slawomir Majewski, Independent Chairman of the Board
George Anders, Director
Ireneusz Fafara, Independent Director
Heman Chao, Chief Executive Officer, Chief Scientific Officer, Director
Theordore Witek, Director
Zbigniew Markowski, CEO
Sylwester Cacek, Director
Sven Rohmann, Chairman of the Board
Photios Michalargias, Chief Financial Officer
Patrick Frankham, COO

HELIX Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HELIX BIOPHARMA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards HELIX BIOPHARMA in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, HELIX BIOPHARMA's short interest history, or implied volatility extrapolated from HELIX BIOPHARMA options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HELIX BIOPHARMA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Complementary Tools for HELIX Stock analysis

When running HELIX BIOPHARMA's price analysis, check to measure HELIX BIOPHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HELIX BIOPHARMA is operating at the current time. Most of HELIX BIOPHARMA's value examination focuses on studying past and present price action to predict the probability of HELIX BIOPHARMA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HELIX BIOPHARMA's price. Additionally, you may evaluate how the addition of HELIX BIOPHARMA to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Commodity Directory
Find actively traded commodities issued by global exchanges
Please note, there is a significant difference between HELIX BIOPHARMA's value and its price as these two are different measures arrived at by different means. Investors typically determine if HELIX BIOPHARMA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HELIX BIOPHARMA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.